This hypothesis was tested by examining the EMT-related biomarkers Vimentin and E-Cadherin in GC and metastatic lymph nodes with IHC, which showed that the level of GAL-1 was related to EMT in GCT. The gene discussed is CDH1; the disease is gastric cancer.